Trial Profile
Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs TAK 114 (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 02 Nov 2011 Results presented at the 76th Annual Scientific Meeting of the American College of Gastroenterology.
- 24 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Oct 2010 New trial record